If you would like to submit a blog post for consideration, please email firstname.lastname@example.org
Artificial intelligence has the capacity to revolutionise skin cancer medicine, with multiple programs in development that aid in the early detection of the disease. One such program is Doctor Hazel – a platform that could someday identify cancerous moles with a success rate of 90 percent, provided it attracts enough user submissions.
Still in its infancy, Doctor Hazel was demonstrated earlier this week by a team of engineers at TechCrunch’s Disrupt San Francisco 2017 hackathon. The artificial intelligence program currently identifies cancer at an 85 percent success rate; however, the team has launched a beta and is inviting users to submit their own photos to improve the platform’s performance.
This month’s research article is a scholarly review from the British Journal of Dermatology. The topic of the article is actinic keratosis (AK), which is such a common condition – and $1 billion is spent in the US each year treating it. Continue reading “Treating Actinic Keratosis In Primary Care”
This week we have an excellent case from Dr Ross Baverstock. A 48 year old male presented for a routine skin check with skin type 3. Dr Baverstock noticed lots of benign looking naevi but one of them stood out in the right scapular area. Continue reading “Case discussion: How would you treat this patient? [18 September]”
Vitamin B3 could potentially help prevent melanoma in people most at risk of developing the deadly skin cancer, according to a paper published in the Photodermatology, Photoimmunology & Photomedicine journal.
The paper’s author, Dr Gary Halliday, wrote that nicotinamide (or vitamin B3), was shown to reduce the incidence of non-melanoma skin cancer in high-risk individuals in a clinical trial called ONTRAC.
The Professor of Dermatology at the University of Sydney believes it would be worthwhile to further determine whether the vitamin can help prevent melanoma in high-risk patients such as outdoor workers, people with fair skin, and those aged over 40.
Dr Halliday said that vitamin B3 ought to be investigated as an inexpensive way of preventing the disease in people who are most susceptible to developing it, since nicotinamide has been proven to enhance DNA repair and reduce inflammation caused by UV radiation.
While such a clinical trial would be welcomed, it is important to await the results of a study before recommending vitamin B3 as a preventative measure for melanoma, which is the fourth most common cancer in Australia.
(10 August 2017) Vitamin B may help prevent melanoma. SBS.
You might be interested in:
- Professional Certificate of Skin Cancer Medicine | Enrol now
Dermoscopy | Biopsy techniques | Surgical treatments | Topical treatments | Medicare billing
- Advanced Certificate of Skin Cancer Medicine | Enrol now
Advanced dermoscopy | Curettage & Cautery | Diathermy | Lower leg grafts | Large ellipses
- Professional Certificate of Skin Cancer Surgery | Enrol now
Rotation flaps | Advancement flaps | Full thickness grafts | Dog ear repairs | Anaesthetic blocks
- Professional Diploma of Skin Cancer Surgery | SOLD OUT
Bilobed flaps | Reconstruction of lower eyelids, lip & ear defects | Anatomy | Perforator island flaps
Further dates and locations
This week we have another engaging case discussion from Dr Slavko Doslo. A 76-year-old patient presented for ROS.
What do you think of this clinical image? What is your impression? (Ignore the adjacent scar).
In the short video below, Professor Wilkinson speaks about the Skin Cancer Medicine course which has been purpose-built to help busy general practitioners acquire the fundamental skills they need to manage skin cancer with confidence and feel safe in their practice. Please take the opportunity to learn more about Australia’s leading professionally accredited skin cancer education program. Continue reading “Professional Certificate of Skin Cancer Medicine with Prof David Wilkinson”
This week we have an interesting case discussion from Dr Gehad Hassanein. A female patient in her mid-40s reported a long standing lesion with a recent change in colour.
What is your evaluation and what would you do (if anything)?
In this skin cancer update, Associate Professor Giuseppe Argenziano discusses the findings of a study from May 2017 about the accuracy of pathologists’ diagnoses of melanoma.
The study found that the accuracy and reproducibility of the pathologists’ results were very low – in some cases, accuracy was just 25 percent.
Genetic changes in melanomas on the hands and feet (acral) and internal surfaces (mucosal) are completely different to the mutations found in skin melanoma, according to a study forming part of the Australian Melanoma Genome Project. The findings confirm the diseases as being very distinct from each other.
The American Society of Clinical Oncology recently brought together around 30,000 oncology professionals for its annual meeting, which this year focused on the latest research in melanoma treatments. Of particular interest were the findings of a number of recent studies and clinical trials that tested the safety and efficacy of various skin cancer treatments.